Tyler Zeronda - May 31, 2022 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role: CFO
Signature: /s/ Mutya Harsch, attorney-in-fact for Tyler Zeronda
Stock symbol: VYNE
Transactions as of: May 31, 2022
Transactions value $: $4,332
Form type: 4
Date filed: 6/2/2022, 04:36 PM
Previous filing: Apr 4, 2022
Next filing: Jul 5, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VYNE	Common Stock	Award	$4.33K	+12.5K	+7.74%	$0.35	174K	May 31, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were acquired under the Issuer's Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2021 and ending on May 31, 2022 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on May 31, 2022 (the last trading day of the offering period).

Content

These shares were acquired under the Issuer's Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2021 and ending on May 31, 2022 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on May 31, 2022 (the last trading day of the offering period).